The formal reports of the work conducted by the MicroArray Quality Control (MAQC) consortium lay the groundwork for microarrays to gain acceptance as a clinical diagnostic and drug development tool.

The potential medical applications of microarrays have generated much excitement, and some skepticism, within the biomedical community. Some researchers have suggested that within the decade ...

The main conclusion: consistency across sites and between platforms is generally high. For instance, "all one-color microarray platforms had a median CV [coefficient of variance] of 5-15% for the ...

Stratagene Corporation has highlighted the U.S. Food and Drug Administration's (FDA) publication of results from its MicroArray Quality Control (MAQC) project. As part of the FDA's Critical Path ...

The FDA's Microarray Quality Control project has delivered a badly needed endorsement of the microarray technologies out on the market. Spurred by studies that suggested varying results among the ...